Study links maternal exposure to chemicals in lotions, shampoos with asthma risk in kids
New Delhi, Nov 19 (IANS) Babies born to mothers with exposure to everyday chemicals present in lotions and shampoos during pregnancy may be at high risk of developing allergic diseases such as asthma, according to a study. Researchers at Kumamoto University analysed data from over 3,500 mother-child pairs to find a potential link between exposure
New Delhi, Nov 19 (IANS) Babies born to mothers with exposure to everyday chemicals present in lotions and shampoos during pregnancy may be at high risk of developing allergic diseases such as asthma, according to a study.
Researchers at Kumamoto University analysed data from over 3,500 mother-child pairs to find a potential link between exposure to certain everyday chemicals during pregnancy and the development of asthma in children.
The findings published in the journal Environmental Pollution showed that exposure to high levels of butylparaben — a chemical commonly used in personal care products like lotions and shampoos — during early pregnancy was associated with a 1.54-fold increase in the risk of asthma in children.
The study also showed that boys born to mothers exposed to 4-nonylphenol — a chemical found in some cleaning products and plastics — had 2.09 times higher odds of developing asthma. However, no such association was observed in girls.
“These results emphasise the need for careful evaluation of chemical exposure during pregnancy,” said Dr. Shohei Kuraoka from Kumamoto University.
“Understanding these risks allows us to develop better guidelines to protect maternal and child health,” Kuraoka added.
The team researchers measured 24 types of phenols in urine samples collected from pregnant women.
They then tracked the health of their children until the age of four. The findings highlight the importance of understanding how everyday chemical exposures might contribute to respiratory and allergic conditions in children.
Some phenols, such as nonylphenol, are known to be endocrine disruptors. Previous studies have shown that exposure to them has contributed to the recent increase in allergic diseases such as asthma.
While the study provides groundbreaking insights, the researchers also acknowledge limitations, such as not measuring phenol levels in children directly. They urged the need for future studies to explore these mechanisms further and establish safe exposure thresholds.
–IANS
rvt/
Mango Kernel Tragedy: Death Toll Rises to 3
Next ArticleOdisha: Kamakshyanagar Sub-Collector Arrested in DA Case
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
